Asarfi Hospital FY26 Profit Hits ₹16.7 Crore, Revenue at ₹173.5 Crore

What just happened

Asarfi Hospital Limited has reported a strong fiscal performance for FY26, with consolidated revenue rising to ₹173.5 crore from ₹121.8 crore in the previous year. Profit After Tax (PAT) witnessed a significant jump of 58%, reaching ₹16.7 crore, supported by improved operating efficiencies and higher patient throughput.

Why this matters

The results signal a successful scaling of operations for the hospital. The company maintained a steady EBITDA margin of 20%, bringing its total EBITDA to ₹35.3 crore for the year. The firm's 'Vision 2028' roadmap, which targets a revenue of ₹400 crore and EBITDA margins of 23-25%, provides a clear growth trajectory for investors looking at the company's long-term integration of healthcare and medical education.

Strategic Developments

Asarfi Hospital is currently operating 350 beds and aims to expand this capacity to over 500 beds by FY28. A notable strategic move is the partnership with Gleneagles Hospital, Chennai, to establish Jharkhand's first Multi-Organ Transplant Unit. Furthermore, the company is building a Healthcare Management & Research Institute in Ranchi, with academic programs scheduled to commence by FY28.

Risks to watch

Investors should monitor the heavy capital expenditure required for the 'Vision 2028' expansion and the reliance on upcoming regulatory approvals. Additionally, the company noted a recent decline in oncology revenues attributed to lower patient volumes and a temporary pause in government-funded healthcare schemes, which may pose a short-term challenge to top-line growth.

What to track next

Watch for the operational timeline of the transplant unit and the progress of the education foundation’s new course certifications. The ability of the management to maintain healthy operating margins while executing these large-scale infrastructure and educational projects will be critical for sustaining shareholder value.